Towards the standardization of mesenchymal stem cell secretome-derived product manufacturing for tissue regeneration

B Chouaib, M Haack-Sørensen, F Chaubron… - International Journal of …, 2023 - mdpi.com
Mesenchymal stem cell secretome or conditioned medium (MSC-CM) is a combination of
biomolecules and growth factors in cell culture growth medium, secreted by mesenchymal …

Mechanotransduction and stiffness-sensing: mechanisms and opportunities to control multiple molecular aspects of cell phenotype as a design cornerstone of cell …

M Selig, JC Lauer, ML Hart, B Rolauffs - International journal of molecular …, 2020 - mdpi.com
Since material stiffness controls many cell functions, we reviewed the currently available
knowledge on stiffness sensing and elucidated what is known in the context of clinical and …

Mechanical considerations of electrospun scaffolds for myocardial tissue and regenerative engineering

M Nguyen-Truong, YV Li, Z Wang - Bioengineering, 2020 - mdpi.com
Biomaterials to facilitate the restoration of cardiac tissue is of emerging importance. While
there are many aspects to consider in the design of biomaterials, mechanical properties can …

Mesenchymal stem cells and their exocytotic vesicles

H Cai, H Guo - International Journal of Molecular Sciences, 2023 - mdpi.com
Mesenchymal stem cells (MSCs), as a kind of pluripotent stem cells, have attracted much
attention in orthopedic diseases, geriatric diseases, metabolic diseases, and sports …

Targeting angiogenesis in myocardial infarction: Novel therapeutics

J Li, Y Zhao, W Zhu - Experimental and therapeutic …, 2022 - spandidos-publications.com
Acute myocardial infarction (AMI) remains the main cause of mortality worldwide. Despite
surgery and medical treatment, the non‑regeneration of dead cardiomyocytes and the …

Harnessing cell-material interactions to control stem cell secretion for osteoarthritis treatment

N Lagneau, P Tournier, F Nativel, Y Maugars… - Biomaterials, 2023 - Elsevier
Osteoarthritis (OA) is the most common debilitating joint disease, yet there is no curative
treatment for OA to date. Delivering mesenchymal stromal cells (MSCs) as therapeutic cells …

A novel method to improve the osteogenesis capacity of hUCMSCs with dual‐directional pre‐induction under screened co‐culture conditions

Q Rong, S Li, Y Zhou, Y Geng, S Liu, W Wu… - Cell …, 2020 - Wiley Online Library
Abstract Objectives Mesenchymal stem cells (MSCs) based therapy for bone regeneration
has been regarded as a promising method in the clinic. However, hBMSCs with invasive …

Therapeutic angiogenesis in coronary artery disease: a review of mechanisms and current approaches

B Narasimhan, H Narasimhan… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Despite tremendous advances, the shortcomings of current therapies for
coronary disease are evidenced by the fact that it remains the leading cause of death in …

Biopolymer hydrogel scaffold as an artificial cell niche for mesenchymal stem cells

MN Egorikhina, YP Rubtsova, IN Charykova… - Polymers, 2020 - mdpi.com
The activity of stem cell processes is regulated by internal and external signals of the cell
“niche”. In general, the niche of stem cells can be represented as the microenvironment of …

[HTML][HTML] Uninterrupted dynamic stiffening microenvironment enhances the paracrine function of mesenchymal stem cells for vascularization through chromatin …

Z Chen, Y Lv - Materials & Design, 2022 - Elsevier
The stiffness of extracellular matrix is dynamically stiffened during bone formation. Paracrine
of angiogenic factors in mesenchymal stem cells (MSCs) plays an essential role during …